Severe acute respiratory syndrome virus 2 (SARS-CoV-2) invades host cells by interacting
with receptors/coreceptors, as well as with other cofactors, via its spike (S) protein that …

The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) poses a persistent threat to global public …

Background Understanding the T cell response to SARS-CoV-2 is critical to vaccine
development, epidemiological surveillance and disease control strategies. This systematic …

Background Mutations accrued by SARS-CoV-2 lineage P. 1—first detected in Brazil in early
January, 2021—include amino acid changes in the receptor-binding domain of the viral …

Severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) has led to the coronavirus
disease 2019 (COVID–19) pandemic, severely affecting public health and the global …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been
detected in almost all organs of coronavirus disease-19 patients, although some organs do …

Soluble forms of angiotensin-converting enzyme 2 (ACE2) have recently been shown to
inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We report …

In December 2019, an outbreak of a novel coronavirus (SARS-CoV-2) in Wuhan, China
resulted in the current COVID-19 global pandemic. The human immune system has not …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel coronavirus
that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19) …

Here, we present evidence that caveolae-mediated endocytosis using LDLR is the pathway
for SARS-CoV-2 virus internalization in the ocular cell line ARPE-19. Firstly, we found that …